Determining sentinel lymph node (SLN) status is critical to cancer staging and treatment decisions. Currently, in clinical practice, 99m Tc-radiocolloid-mediated planar scintigraphy and single-photon emission computed tomography (SPECT) are used to guide the biopsy and resection of SLNs. Recently, an emerging technique that combines positron emission tomography (PET) and photoacoustic tomography (PAT; PET-PAT) may offer accurate information in detecting SLNs. Herein, we report a kind of 64 CuS-labeled nanoparticle ( 64 CuS-NP) for the detection of SLNs with PET-PAT. We subcutaneously injected 64 CuS-NPs into the rats' forepaw pads. After 24 h, the rats' first draining axillary lymph nodes (i.e. the SLNs) could be clearly visualized with micro-PET (μPET)-CT. Rats were sacrificed after μPET-CT imaging, their axillary lymph nodes were surgically identified, and then PAT was employed to discover 64 CuS-NP-avid SLNs, which were embedded inside tissues. Biodistribution, autoradiography, and copper staining analyses confirmed the SLNs' high uptake of 64 CuS-NPs. Our study indicates that 64 CuS-NPs are a promising dualfunction agent for both PET-CT and PAT and could be used with multi-modal imaging strategies such as PET-PAT to identify SLNs in a clinical setting. /journal/cmmi and left axillary LNs near the chest of a rat. The red arrows indicate the direction of lymph drainage. (C) Hematoxylin and eosin staining of a left axillary LN containing no 64 CuS-NPs (left) and a right axillary LN containing 64 CuS-NPs (right; magnification × 400). The yellow arrows indicate the particles, which are 64 CuS-NPs, distributed among lymphocytes.
INTRODUCTION
Sentinel lymph nodes (SLNs) are the first lymph nodes (LNs) to which cancer cells from the primary tumor are most likely to metastasize. SLN status is an important factor in both staging disease and determining prognosis (1) (2) (3) . Thus, accurately locating SLNs for biopsy is often the first step in therapeutic decisionmaking.
Currently, blue dyes (e.g. Evans blue, methylene blue, patent blue V), radioisotopes containing 99m Tc, or both are mostly used (4) . 99m Tc-labeled tracers used for SLN mainly include 99m Tcnanocolloid human serum albumin, 99m Tc-antimony trisulfide or 99m Tc-tilmanocept (5, 6) . However, blue dyes have poor retention in LNs, adding to the difficulty in locating and removing SLNs; moreover, these dyes are only useful for the visualization of superficial LNs (7) . On the other hand, scintigraphy and single-photon emission computed tomography (SPECT) with 99m Tc have relatively low spatial resolution. As a result, if the SLNs are close to the tumor or the injection site, it is difficult to separate the hot spot of the nodes from that of the primary tumor or injection site.
Apart from traditional imaging techniques, one emerging imaging modality that has shown promise for mapping SLNs is photoacoustic tomography (PAT). PAT, a hybrid modality that combines the advantages of optical excitation and acoustic detection, can be used to detect SLNs with high sensitivity deep in the soft tissue (8, 9) , and a handheld, array-based PAT probe has been developed for this purpose (10, 11) . In recent years, a number of newer-generation SLNs imaging probes have been developed, such as fluorophores (12) , microbubbles (13) , and other nanoparticles (14) (15) (16) . Nanoparticles were mainly distributed in interstitial space, from which the particles drained into the LNs via the lymphatic system. Subsequently, SLNs phagocytose these nanoparticles, causing them to accumulate within the LN (17, 18) . With the development and maturation of hybrid systems, multi-modality imaging agents based on promising nanocarriers have been investigated for SLN mapping, with high accuracy.
CuS-NPs, our original dual-modality imaging agent, can provide sufficient contrast to non-invasively identify SLNs with a PAT system. Moreover, these CuS-NPs can be easily labeled as 64 CuS-NPs for PET-CT. For cancer patients, PET-CT imaging can provide significant information for diagnosing and staging, as well as yielding operation positioning and absolute quantification, which is very helpful for preoperative planning. PAT with sensitive and high-resolution portable optical imaging devices permits real-time imaging of SLNs, enabling image-guided treatment to be performed by the operating surgeon. Here, we report a new dual-modality imaging agent, 64 CuS-NPs, for PET-PAT mapping of SLNs.
METHODS

64 CuS-NP synthesis: characterization and radiolabeling
The procedure for the synthesis and 64 Cu-radiolabeling of CuS-NPs has been described in detail previously (19) . For the synthesis of 64 CuS-NPs, 20 μL of 64 CuCl 2 (1000 μCi) was added to 1 mL of a CuCl 2 solution (1 mM) containing 1 mg of PEG (polyethylene glycol)-SH. Then, 10 μL of sodium sulfide solution (100 mM) was added to the CuCl 2 solution under stirring. The mixture was then heated to 90°C for 15 min until a dark-green solution was obtained. The reaction mixture was transferred to an ice-cold water bath to yield 64 CuS-NPs (average size 11 ± 3 nm). The identity and crystallinity, size, and shape of the NPs were observed by X-ray diffraction and a high-resolution transmission electron microscope (200 kV, JEOL, Japan). X-ray diffraction was performed using a Siemens Kristalloflex 810 D-500 X-ray diffractometer (Siemens, Germany) under an operating mode of 40 kV and 30 mA with λ = 1.5406 Å radiation.
The radiolabeling efficiency and stability of the 64 CuS-NP was analyzed using instant thin-layer chromatography (ITLC). The ITLC strips were developed with phosphate-buffered saline (pH 7.4) containing 4 mM ethylenediaminetetraacetic acid and quantified with an IAR-2000 ITLC imaging scanner (Bioscan, Washington, DC, USA). To study labeling stability, 64 CuS-NPs were suspended in PBS or mouse serum and incubated at 37°C for 24 h. Free 64 Cu 2+ ions moved to the solvent front, and the NPs remained at the original location. The radioactivity at the original location was recorded as a percentage of the total radioactivity of the ITLC strip.
Animal preparation
All experiments involving animals were approved by MD Anderson's Institutional Animal Care and Use Committee. Eight 5-6 week old female Sprague Dawley rats (Charles River Laboratories, Houston, TX, USA), each weighing 250-300 g, were maintained under specific pathogen-free conditions.
μPET-CT
All the rats received a 20 min scan by an Inveon (μPET)-CT scanner (Siemens Preclinical Solutions, Knoxville, TN, USA). The spatial resolution of the PET system is approximately 1.4 mm. We subcutaneously injected 64 CuS-NPs (8 × 10 10 particles/mouse, 200 μCi/mouse; 0.2 mL) into the right forepaws of the five rats. Twenty-four hours after the 64 CuS-NP injection, all rats were subjected to μPET-CT. The rats were anesthetized with 2% isoflurane and then placed in a prone position. PET and CT images were acquired separately and then fused in the Inveon Research Workplace (Siemens Preclinical Solutions). Images were reconstructed using the two-dimensional ordered-subsets expectation maximization algorithm using 16 subsets and four iterations. For data analysis, the region of interest covering the whole LNs on the CT images was manually drawn and then copied onto the corresponding PET images. Similarly, a circular region of interest on the muscle covering the corresponding area of the opposite shoulder of the rat on the CT images was drawn and then copied onto the PET images. The mean signal intensities of the LN and muscle in the regions of interest were recorded. Tracer uptake was calculated as %ID/g and presented as mean ± standard deviation.
Biodistribution, histopathology, and autoradiography
Immediately after μPET-CT, three rats were humanely killed by excessive inhalation of carbon dioxide. Heart, liver, spleen, kidney, lung, stomach, intestine, muscle, bone, brain, and LNs from both sides were excised and weighed, and their radioactivity was measured with a Packard Cobra Gamma Counter (GMI, Ramsey, MN, USA). The 64 Cu-NP uptake in the various organs was calculated as %ID/g.
LNs from both sides of three rats were removed, first for biodistribution study, and after that the LNs were snap-frozen with optimum-cutting-temperature compound (Sakura Finetek, Torrance, CA, USA) and sliced into six to eight consecutive 5 μm sections. To show changes and the distribution of 64 CuS-NPs in the SLNs, two sections were stained with hematoxylin and eosin, two sections were stained for copper, and the remaining sections were exposed to phosphor imaging film for autoradiography.
The rhodanine method was used for copper staining as described previously (20) . Briefly, deparaffinized sections rehydrated in distilled water were placed in a rhodanine solution for 18 h at 37°C, rinsed in distilled water, stained with Mayer's hematoxylin for 10 min, and then rinsed again in distilled water. After a quick wash with 0.5% sodium borate solution, the sections were rinsed with distilled water again, dehydrated, and mounted with synthetic resin on slides for microscopic study.
For autoradiography, the sections were dried at 4°C in the open air, photographed, and exposed on BAS-SR 2025 Fuji phosphor film for 12 h. The film was scanned using an FLA5100 multifunctional imaging system (Fujifilm Life Science, Stamford, CT, USA).
PAT
PAT was performed with an Nd:YAG laser (LS-2137; Symphotic TII, Camarillo, CA, USA) with a pulse duration of less than 15 ns, pulse repetition rate of 10 Hz, and wavelength of 1064 nm. The incident laser fluence on the tissue surface was controlled to be less than 100 mJ/cm 2 , which was the 'maximum permissible exposure' of human skin at the wavelength of 1064 nm according to the American National Standard Institute for the Safe Use of Lasers. Multiple ultrasonic transducers (V323/V310/V312, Panametrics, Waltham, MA, USA) with nominal frequency at 2.25, 5.0, and 10.0 MHz and active element diameter of 6 mm were employed to receive photoacoustic waves. Their corresponding in plane imaging resolutions were estimated to be 0.8, 0.4, and 0.2 mm, respectively. There was a tradeoff between the imaging resolution and sensitivity. The LN photoacoustic image presented was obtained using V310 (21) .
Immediately after μPET-CT imaging the two imaged rats (and also three additional rats treated with 64 CuS-NPs) were humanely killed by excessive inhalation of carbon dioxide. In order to imitate the circumstance in vivo and demonstrate the deep-imaging capabilities of PAT, a piece of chicken breast muscle about 10 mm in thickness was added between the rat skin and LNs, and then PAT was performed. A needle tip was also embedded across the LN as a photoacoustic indicator.
Ultrasonic transducers were placed approximately 5 cm from the imaging field, and continuously scanning around the test sample was employed to complete one circular scan in 5 min to detect photoacoustic signals ( Supplementary Material 1) . 2400 time frame signals were recorded for image reconstruction using a filtered back projection algorithm. Photoacoustic signals were amplified by 35 dB using a pulse-receiver (5072PR; Olympus, Waltham, MA, USA) and then recorded with a data acquisition card (CompuScope 14200; GaGe Applied, Lockport, IL, USA).
Statistical analyses
Data were expressed graphically as the mean ± SEM of the different variables. t tests using Microsoft Excel 2007 (Microsoft Corporation, China) were performed to compare the uptake values for 64 CuS-NPs of the LNs from both sides of the rats. A P value of less than 0.05 was considered statistically significant.
RESULTS
Characterization and stability
The results of X-ray diffraction and transmission electron microscopy indicated that no obvious impurity peaks were detected and the CuS-NPs were well dispersed and relatively uniform in size, with an average diameter of 11 nm. Therefore, we can conclude that we had made pure high-quality CuS-NPs. From the ITLC synthesis, the radiolabeling efficiency of 64 CuS-NPs approached 100%. After incubation in PBS and FBS at 37°C for 24 h, a negligible amount of radioactivity was lost, and the radiolabeling efficiencies of 64 CuS-NPs were 99.8% and 99.2%, respectively.
μPET-CT
Following subcutaneous injection of 64 CuS-NPs, μPET-CT clearly showed the right axillary LNs near the arm and near the chest, which is a single group of subaxillary LNs, but not the left axillary LNs ( Figure 1A) . 64 CuS-NPs demonstrated excellent specificity to SLNs, with high signal-to-background ratio (SLN-to-muscle ratio = 28.7). The uptake values of the right axillary LNs on μPET-CT (3.34 ± 0.46 %ID/g) were substantially higher than those of the left axillary LNs (0.85 ± 0.25 %ID/g). The anatomical locations of the axillary LNs were consistent with the locations of the 64 CuS-NP-avid areas in the μPET-CT images (22) . Figure 1B shows both the right axillary and left axillary LNs. The right axillary LNs were clearly imaged on μPET-CT, but the left axillary LNs cannot be seen in the images.
Biodistribution of 64 CuS-NPs
The biodistribution of 64 CuS-NPs subcutaneously injected into the right forepaw, as assessed by the cut-and-count method, is shown in Figure 2 . The 64 CuS-NP uptake in the right axillary LNs (4.06 ± 1.19 %ID/g) was significantly higher than that in the left axillary LNs (0.45 ± 0.45 %ID/g; p < 0.05). After the right axillary LNs, the kidneys had the highest 64 CuS-NP uptake (2.3 ± 0.9 %ID/g). The 64 CuS-NP uptake of other tissues was significantly lower than that of the LNs. Therefore, 64 CuS-NPs were primarily taken up by SLNs, and with the exception of the kidneys other organs had very little 64 CuS-NP uptake. These results were consistent with the μPET-CT findings.
Autoradiography and histopathology
Autoradiography confirmed the distribution of 64 CuS-NPs in the LNs (Figure 3) . Compared with the right axillary LNs, the left axillary LNs had no detectable radioactivity ( Figure 3A, B) . Autoradiography clearly demonstrated that the distal LNs had more 64 CuS-NPs than the proximal LNs did, which is consistent with the direction of lymphatic drainage. Hematoxylin and eosin staining revealed that the interstitial was not clean and there were some particles distributed among lymphocytes in the right axillary LNs but not the left axillary LNs ( Figure 3C ). Copper staining confirmed the presence of 64 CuS-NPs in the right axillary LNs and not the left axillary LNs (Figure 4 ).
PAT
A total of five rats (two after PET-CT, and three additional rats) were imaged by photoacoustic imaging on their axillary LNs. PAT images clearly discovered the nanoparticles by ipsilateral draining of LNs after interstitial injection of CuS-NPs. Figure 5 shows a photograph and PAT image of an LN. Because of the uptake of CuS-NPs, the LN structure contour and nanoparticle distribution inside the LN were visible. For this imaging depth and experimental conditions, the PAT resolution and sensitivity ensure the detection of the nanoparticles. Quantitative comparisons were also applied; the photoacoustic signal intensity of each image pixel within the LN region of a rat was acquired and used to calculate the mean and standard deviation of photoacoustic signal intensity. The photoacoustic signal intensity was much higher in LNs with CuS-NP uptake versus the LNs without CuS-NPs (7.85 ± 3.78 versus 2.46 ± 0.73 a.u., p = 0.026).
DISCUSSION
Our results were consistent with the study of Pan et al., which demonstrated the high signal of copper neodecanoate NPs in SLN photoacoustic imaging (23) . Notably, the accumulation of contrast agent in liver is relative lower in our study at 24 h after subcutaneous injection (21.3 ± 7 versus 0.7 ± 0.2 % ID/g) when compared with the study by Pan et al., which may be because the average size of their copper NPs was 86 nm while ours was 11 nm. Several studies used gold nanomaterial as LN tracer, such as gold nanocages (AuNCs) and gold nanorods (14, 24, 25) . However, one study found that there was no clearance of AuNCs in a rat model within 5 h (26) . The prolonged accumulation of AuNCs might cause systemic toxicity. In our study, by a simple replacement reaction (19) , we radiolabeled CuS-NPs with 64 Cu and can detect SLNs via PET-CT imaging with excellent specificity (SLN-to-muscle ratio = 28.7). Furthermore, CuS-NPs as a PAT agent are very promising in intraoperative detection of SLNs, because SLNs containing CuS-NPs at a depth of approximately 5 cm could be clearly visualized non-invasively, and the PAT instrument is relatively convenient (21) .
In addition to nuclear imaging, optical imaging such as nearinfrared fluorescence imaging with low-molecular-weight organic dyes and nanoparticles has been investigated as a potential SLN imaging technique (27) (28) (29) . However, even in the near-infrared region, tissue penetration remains a major limitation in imaging LNs located deep in the soft tissue. With the development and maturation of hybrid systems such as PET-CT, PET-magnetic resonance imaging (MRI), and PET-optical imaging, recent research has focused on the development of multifunctional lymphatic mapping agents with a single platform (30, 31) . We and others have reported polymer-based agents for dual-modal MRI-near-infrared fluorescence imaging, which may overcome the limitation posed by the depth of some LNs (32, 33) . Unfortunately, to improve the low sensitivity of MRI, large doses of gadolinium-containing contrast agents must be injected, which raises concerns about their potential long-term toxicity. Additionally, compared with MRI, PET-CT can offer distant metastasis information.
PAT is a non-invasive, low-cost imaging modality (34, 35) . We have previously shown that CuS-NPs can be used with PAT to visualize targets in a chicken breast muscle phantom approximately 5 cm from the laser irradiation surface (21) . Building on this experience, in the current study, we showed that SLNs at a depth of approximately 10 mm could be clearly visualized with a prototype PAT system after subcutaneous injection of 64 CuS-NPs. The major advantage that CuS-NPs have as an efficient PAT imaging agent is that their absorption peak can be tuned to approximately 1064 nm in the second near-infrared optical window. At this wavelength, light encounters less tissue attenuation. Moreover, the Q-switched Nd:YAG laser emits 1064 nm laser light to deliver the highest output energy possible, because it is used to obtain tunable laser output at other wavelengths in the near-infrared region with substantial energy loss. Higher laser energy translates into a stronger photoacoustic signal and a higher signal-to-noise ratio. The uptake of CuS particles was clearly imaged using the homemade experimental imaging device with high sensitivity. However, the device configuration requires the sample to be surrounded by detectors. For future human subjects, other configurations such as aligning the ultrasound detector along one side or both sides of an object need to be explored, although the PAT imaging resolution and sensitivity will be consequently decreased.
Used alone, PAT and PET-CT have certain limitations. PAT alone is not suitable for imaging all LNs, especially those located deep in the body. On the other hand, PET-CT alone, owing to its high cost and the radiation exposure to health care providers, may have limited use for SLN mapping during SLN biopsy procedures. Our dual-modality agent 64 CuS-NPs, which combines PAT and PET-CT imaging, can provide cross-sectional images for presurgical planning by PET-CT imaging as well as intra-operative mapping via PAT detection. More importantly, it also allows the detection of SLNs quantitatively, regardless of depth and whole-body scanning.
Positioning SLNs by the dual-modality agent 64 CuS-NPs has great value for cancer patients. First, as a PAT contrast agent, it helps to detect SLNs with high sensitivity and accuracy and the PET signals it yields can provide a direct approach to validate the PAT result by one-time injection. Second, 64 CuS-NPs as a tumor targeting agent, based on the EPR (enhanced permeability and retention) effect, can also offer information for primary lesions and distant metastases (19) . Third, 64 CuS-NPs are simply synthesized, low cost, and have good biocompatibility and longer imaging times due to the longer half-life (12.7 h) of 64 Cu. Compared with our previous study, the dose used in the current study is lower (7.4 MBq, 4 × 10 13 NPs, per nude mouse versus 7.4 MBq, 8 × 10 10 NPs, per rat) (36) . As a result, there is no obvious toxicity to the animals in SLN imaging. Additionally, our previous studies have shown that there were no obvious signs of toxic effects in the CuS-NP-injected mice (36, 37) . Lu et al. have validated that CuS-NPs showed a faster clearance in vivo and can be considered to be biodegradable when compared with gold nanoparticles (38) . Study has also demonstrated that CuS-NPs are active catalysts for bisulfide oxidation in vivo, and sulfidation can reduce Cu solubility, redox activity, and cytotoxicity (39) .In future studies, PET-PAT with 64 CuS-NPs will be used in animal tumor models to fully demonstrate the imaging characteristics of LNs with metastatic lesions.
CONCLUSION
64 CuS-NPs, which had excellent retention in the SLNs after subcutaneous injection, could be used with PET-PAT to map SLNs. This can not only show SLNs with high sensitivity and resolution but also offer information on distant metastases. Our study provides groundwork for employing a multimodal imaging strategy to image SLNs in a clinical setting.
